Blog Posts
Cell and Gene Therapy in 2023 – It’s All About Access
This year, thousands of cell and gene therapy clinical trials are running around the world. Some of those studies have...
2022 Year in Review: Integration, Innovation, Inspiration
In challenging times, some companies must just try to hang on. At CSafe, we’ve faced another year of unprecedented change...
Pharma cold chain: Consider ‘Hibernation’ when potential losses are unbearable
The old proverb — the best-laid plans … often go awry — becomes quite relevant in the preparation, transport and...
Cell & Gene Therapy Logistics Planning and Scaleup
The vibrant and growing pipeline of cell and gene therapies (CGT) provides many exciting clinical opportunities for patients and their...
Cold-chain shipping containers: Quality matters
The adage “quality begets quality” — a fundamental underpinning of all mechanically engineered systems — should be top of mind...
Reducing temperature excursions in cold chain shipping — The business imperative for using phase-change materials (PCM)
Prolonged temperature excursion is the greatest enemy in the world of temperature controlled pharmaceutical shipping. Selecting the most appropriate cargo...
Air Cargo Shipment Data in Real-time: Access Options for Every Stakeholder
When it comes to shipping temperature-sensitive pharmaceutical products, there is little room for error. Throughout the journey, everything must go...
Cell & Gene Therapy Commercialization Logistics: 3 Critical Questions to Ask when Choosing a Thermal Shipping Container
Among today’s temperature-sensitive pharmaceutical products requiring specialized handling, transport and storage, cell and gene therapies (CGT) need even more precise...
Ensuring GDP Compliance with Shipment Visibility
Across the pharmaceutical and healthcare landscape, an increasing volume of approved pharmaceutical products must be temperature controlled from the moment...
Cell and gene therapies: Managing COVID-19 disruptions, both upstream and downstream
The time-sensitive, temperature-sensitive supply chain for cell-and-gene therapies (CGT) requires a highly coordinated, highly choreographed dance under the best of...